The Patent Finder

Conjugates of an IL-2 Moiety and a Polymer

Nektar Therapeutics

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2011/060408, filed Nov 11, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,861,705Conjugates of an IL-2 Moiety and a Polymer
In force
 · High confidence
UsedRemaining
Nektar TherapeuticsIn forceHigh confidence
US 10,960,079Conjugates of an IL-2 Moiety and a Polymer
In force
 · High confidence
Nektar TherapeuticsIn forceHigh confidence
US 11,091,525Method of Refolding an INTERLEUKIN-2 (IL-2) Protein
In force
 · High confidence
Nektar TherapeuticsIn forceHigh confidence
US 12,247,059Conjugates of an IL-2 Moiety and a Polymer
In force
 · Medium confidence
Nektar TherapeuticsIn forceMedium confidence
Application 17/003,847Conjugates of an IL-2 Moiety and a Polymer
Abandoned
Abandoned Nov 2, 2023
Nektar TherapeuticsAbandonedAbandoned Nov 2, 2023
Application 19/047,443Conjugates of an IL-2 Moiety and a Polymer
Pending
Not granted
Nektar TherapeuticsPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Nektar Therapeutics.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited